attIL12-TIL
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for attIL12-TIL, covering 2026-02-27 to 2026-02-27. Get the full timeline:
Most recent: Clinical Trial Update: T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients. [Phase 1]